Overview

Investigating the Role of 13cis Retinoic Acid in the Treatment of COVID-19 and Enhancement of Its Spike Protein Based Vaccine Efficacy and Safety.

Status:
Not yet recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
Investigating the role of 13cis retinoic acid in the treatment of COVID-19 and enhancement of Its spike protein based vaccine efficacy and safety.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Kafrelsheikh University
Treatments:
Isotretinoin
Myeloma Proteins
Paraproteins
Tretinoin
Vaccines